Search results for “CX3CR1” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 260 patents, we discovered top 27 key players by total patent application. Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA, AstraZeneca Pharmaceutical Co., Ltd., Eisai R&D Management Co., Ltd. are dominant in this area. They take 56.92% of the total patent filing.
Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - SpA
Marche, Italy
Patent: 67
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 44
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 37
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 21
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 18
The Board of Regents of The University of Texas System
Texas, United States
Patent: 11
Kancera AB
Sweden
Patent: 10
Axxam SpA
Lombardia, Italy
Patent: 10
Genentech, Inc.
California, United States
Patent: 8
bioMérieux SA
France
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 66 patents applied in the last 5 years. We discover 26 most active companies in this area. The fast-growing The Board of Regents of The University of Texas System, Axxam SpA, Kancera AB take 46.97% of patent filing during this period.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 11
Axxam SpA
Lombardia, Italy
Patent: 10
Kancera AB
Sweden
Patent: 10
Genentech, Inc.
California, United States
Patent: 8
bioMérieux SA
France
Patent: 6
BioAster
France
Patent: 5
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 4
Ablynx NV
Oost-Vlaanderen, Belgium
Patent: 3
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 3
The Children's Medical Center Corp.
Massachusetts, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 66 patents in last 5 years, we discover 20 new entrants. The Board of Regents of The University of Texas System, Kancera AB, Axxam SpA are the most active new entrants in this area.
The Board of Regents of The University of Texas System
Texas, United States
Patent: 11
Kancera AB
Sweden
Patent: 10
Axxam SpA
Lombardia, Italy
Patent: 10
Genentech, Inc.
California, United States
Patent: 8
bioMérieux SA
France
Patent: 6
BioAster
France
Patent: 5
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 3
The Children's Medical Center Corp.
Massachusetts, United States
Patent: 3
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 2
Mayo Foundation for Medical Education & Research
Minnesota, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 58 patents, we discovered top 13 universities and scientific research institutions by total patent application. Northwestern University, Université Pierre et Marie Curie, Drexel University are dominant in this area. They take 48.28% of the total patent filing.
Northwestern University
Illinois, United States
Patent: 7
Université Pierre et Marie Curie
France
Patent: 5
Drexel University
Pennsylvania, United States
Patent: 4
University of South Florida
United States
Patent: 3
University of Nice Sophia Antipolis
France
Patent: 3
Cornell University
New York, United States
Patent: 2
The Johns Hopkins University
United States
Patent: 2
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 2
Universite De La Mediterranee
France
Patent: 2
Jinan University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: